Presentations and meeting highlights
DOG 2021
Vision Academy members Antonia Joussen, Daniel Pauleikhoff, and Anat Loewenstein presented at the DOG (Deutsche Ophthalmologische Gesellschaft; German Ophthalmological Society) virtual congress in October 2021. View the presentations on the characterization of AMD subtypes and the futility of anti-VEGF treatment, as well as the consecutive panel discussion.
Scandinavian regional webinar
Vision Academy Steering Committee members Anat Loewenstein, Monica Lövestam-Adrian, and David Wong took part in a webinar in November 2020 to debate two key topics: managing occurrences of RPE tear and recommendations on suspending treatment in cases of futility.
Vision Academy Annual Meeting 2020
Dr. William W. Li is the President, Medical Director, and co-founder of the Angiogenesis Foundation in the United States, whose recent work includes research into vascular effects and angiogenesis in COVID-19.
Watch Dr. Li’s presentation from the 2020 Vision Academy Annual Meeting for highlights from his research findings on angiogenesis and COVID-19.
COPHy EU 2020
The 2020 COPHy EU meeting was held as a virtual meeting due to the COVID-19 pandemic. The Vision Academy session included debates on RPE tear and treat-and-extend retreatment/extension decisions. Professor Anat Loewenstein also presented a special session on “Current approaches to intravitreal injections in an era of COVID-19”.
FLORetina 2019
The 3rd biannual Florence Retina Meeting (FLORetina) took place on June 6–9, 2019 in Florence, Italy. The Vision Academy session included debates on Academy recommendations on the management of subfoveal hemorrhage, suspending anti-VEGF treatment in cases of futility, and the optimal treatment regimen with anti-VEGF.
Please email vision.academy@bayer.com to request slides from the expert presentations at FLORetina 2019.
COPHy EU 2019
The 10th Annual Congress on Controversies in Ophthalmology: Europe (COPHy EU) took place on April 4–6, 2019 in Dublin, Ireland. The Vision Academy session included debates on Academy recommendations on monitoring of the fellow eye and treating diabetic retinopathy.
Please email vision.academy@bayer.com to request slides from the expert presentations at COPHy EU.
Vision Academy Annual Meeting 2019
The Vision Academy Annual Meeting took place on March 15–16, 2019 in Amsterdam, the Netherlands. The meeting included updates on clinical challenges for the Academy in 2019, presentations on the clinical implications of the latest ophthalmic data, and discussion on patient engagement and how effective uptake and implementation of treatment guidelines can be achieved.
Please email vision.academy@bayer.com to request slides from the Vision Academy Annual Meeting.
COPHy AA 2019
The 5th Annual Congress on Controversies in Ophthalmology: Asia-Australia (COPHy AA) took place on February 22–23, 2019 in Shanghai, China. The Vision Academy session included debates on Academy recommendations on monitoring of the fellow eye and suspending anti-VEGF therapy in cases of futility.
Please email vision.academy@bayer.com to request slides from the expert presentations at COPHy AA.
COPHy AA 2018
The 4th Annual COPHy AA Congress took place on February 1–4, 2018 in Manila, the Philippines. The Vision Academy session included debates on two published Viewpoints: ‘Fundamental principles of an anti-VEGF treatment regimen’ and ‘Use of topical antibiotics with intravitreal injections’.
